---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-25-007478"
form_type: "8-K"
ticker: "SNOA"
cik: "0001367083"
company_name: "Sonoma Pharmaceuticals, Inc."
filed_at: "2025-10-09T23:59:59+00:00"
generated_at: "2026-05-17T04:10:09.501202+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# CEO Amy Trombly amends employment agreement; COO Bruce Thornton retires, position eliminated

## Summary
- CEO Amy Trombly's base salary set at $475,000 per annum; target annual bonus of 50% of base salary.
- CEO severance: termination without cause or for Good Reason: 1x base salary paid via payroll; COBRA up to 12 months.
- CEO change-in-control severance: 2x base salary + 2x target bonus; COBRA up to 24 months.
- COO Bruce Thornton to retire on Dec 2, 2025; position eliminated; severance $300,000 plus COBRA up to 12 months.
- COO's time-based equity awards fully vest; performance-based awards remain per terms.

## SEC filing metadata
- accession: 0001683168-25-007478
- form_type: 8-K
- ticker: SNOA
- cik: 0001367083
- company_name: Sonoma Pharmaceuticals, Inc.
- filed_at: 2025-10-09T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367083/000168316825007478/0001683168-25-007478-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367083/000168316825007478/sonoma_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-25-007478
- JSON: https://secwatch.observer/filing/0001683168-25-007478.json
- Plain text: https://secwatch.observer/filing/0001683168-25-007478.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.